Have a personal or library account? Click to login
Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells Cover

Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells

Radiology and Oncology
Volume 52 (2018): Issue 4 (December 2018)
By: Tanja Mesti,  Nadia Bouchemal,  Claire Banissi,  Mohamed N. Triba,  Carole Marbeuf-Gueye,  Maja Cemazar,  Laurence Le Moyec,  Antoine F. Carpentier,  Philippe Savarin and  Janja Ocvirk  
Open Access
|Nov 2018

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/raon-2018-0046 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 392 - 398
Submitted on: Nov 30, 2017
|
Accepted on: Oct 21, 2018
|
Published on: Nov 26, 2018
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
idh1 mutation,
malignant glioma,
bevacizumab,
metabolic,
fingerprint
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2018 Tanja Mesti, Nadia Bouchemal, Claire Banissi, Mohamed N. Triba, Carole Marbeuf-Gueye, Maja Cemazar, Laurence Le Moyec, Antoine F. Carpentier, Philippe Savarin, Janja Ocvirk, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 52 (2018): Issue 4 (December 2018)Next article